Ligand Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Ligand Pharmaceuticals Stock Forecast and Price Target
Ligand Pharmaceuticals has an average price target of $110.00 recently offered by three notable experts for 2024, which would represent a potential upside of approximately 55.87% from the last closing price in April, 2024 if reached. This potential increase is based on a high estimate of $144.00 and a low estimate of $95.00. Even if you are not interested in LGND stock, you should still be aware of its competitors.
55.87% Upside
Ligand Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Ligand Pharmaceuticals's Price has fallen from $92.46 to $0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $29.46 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Ligand Pharmaceuticals will be 100.00%.
Ligand Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Ligand Pharmaceuticals's Revenue has fallen from $186.42M to $131.31M – a 29.56% decrease. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach $140.55M – an increase of 7.04%. Over the next seven years, experts anticipate that Revenue growth for Ligand Pharmaceuticals will be 301.36%.
.jpg)
Ligand Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Ligand Pharmaceuticals's EBITDA has decreased from $57.40M to $45.45M – a 20.82% drop. For next year, the 2 analysts predict EBITDA of $100.66M, which would mean an increase of 121.47%. Over the next seven years, the pros' prediction is EBITDAof $102.03M, which would mean a seven-year growth forecast of 124.49%.
Ligand Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
Ligand Pharmaceuticals's EBIT has decreased by 66.63% In the last three years, from $29.43M to $9.82M. In the next year, analysts expect EBIT to reach $25.82M – an increase of 162.93%. For the next seven years, the forecast is for EBIT to grow by 1510.08%.
Ligand Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Ligand Pharmaceuticals's EPS has fallen from $4.55 to $0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $1.45 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Ligand Pharmaceuticals will be 100.00%.
Site Navigation
.jpg)